TRIM24 Is an Oncogenic Transcriptional Activator in Prostate Cancer.

• Groner AC Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
• Cato L Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
• de Tribolet-Hardy J Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
• Bernasocchi T Institute of Oncology Research, Bellinzona 6500, Switzerland.
• Janouskova H Institute of Oncology Research, Bellinzona 6500, Switzerland.
• Melchers D PamGene International, Den Bosch 521HH, the Netherlands.
• Houtman R PamGene International, Den Bosch 521HH, the Netherlands.
• Cato ACB Institute of Toxicology and Genetics, Karlsruhe Institute of Technology, 76344 Eggenstein-Leopoldshafen, Germany.
• Tschopp P Department of Genetics, Harvard Medical School, Boston, MA 02215, USA.
• Gu L Division of Newborn Medicine, Children's Hospital Boston and Department of Cell Biology, Harvard Medical School, Boston, MA 02215, USA.
• Corsinotti A MRC Centre for Regenerative Medicine, Institute for Stem Cell Research, School of Biological Sciences, University of Edinburgh, Edinburgh EH16 4UU, UK; Laboratory Animal Resource Center, Department of Anatomy and Embryology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan.
• Zhong Q Institute of Surgical Pathology, University Hospital Zurich, Zurich 8091, Switzerland.
• Fankhauser C Institute of Surgical Pathology, University Hospital Zurich, Zurich 8091, Switzerland; Department of Urology, University Hospital Zurich, Zurich 8091, Switzerland.
• Fritz C Institute of Surgical Pathology, University Hospital Zurich, Zurich 8091, Switzerland.
• Poyet C Department of Urology, University Hospital Zurich, Zurich 8091, Switzerland.
• Wagner U Institute of Surgical Pathology, University Hospital Zurich, Zurich 8091, Switzerland.
• Guo T Department of Biology, Institute of Molecular Systems Biology, Eidgenössische Technische Hochschule (ETH) Zurich, Zurich 8093, Switzerland.
• Aebersold R Department of Biology, Institute of Molecular Systems Biology, Eidgenössische Technische Hochschule (ETH) Zurich, Zurich 8093, Switzerland; Faculty of Science, University of Zurich, Zurich 8057, Switzerland.
• Garraway LA Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA; The Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
• Wild PJ Institute of Surgical Pathology, University Hospital Zurich, Zurich 8091, Switzerland.
• Theurillat JP Institute of Oncology Research, Bellinzona 6500, Switzerland; The Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne 1011, Switzerland. Electronic address: jeanp_theurillat@ior.iosi.ch.
• Brown M Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA. Electronic address: myles_brown@dfci.harvard.edu.

Show more…

Animals

Carrier Proteins

Cell Proliferation

Disease Progression

Gene Expression Regulation, Neoplastic

Humans

Male

Neoplasm Transplantation

Nuclear Proteins

Prostatic Neoplasms

Prostatic Neoplasms, Castration-Resistant

Receptors, Androgen

Repressor Proteins

Signal Transduction